Parks will spearhead development and execution of Matica Bio’s commercial strategic initiatives as EVP of Commercial Operations Sugrue to advance business development goals, partnerships as VP of ...
COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector development and ...
COLLEGE STATION, Texas, October 24, 2024--(BUSINESS WIRE)--Matica Biotechnology Inc. (Matica Bio), a CDMO specializing in viral vector development and manufacturing, announced the signing of a Letter ...
COLLEGE STATION, Texas, Nov. 3, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a strategic partnership ...
COLLEGE STATION, Texas, Sept. 15, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector ...
Kim to oversee cell and gene therapy (CGT) manufacturing operations, processes, operations, and business strategy as CEO during period of rapid expansion across US and Korea COLLEGE STATION, ...
Matica Biotechnology, a U.S. affiliate of Korea’s CHA Biotech, said Tuesday that it has signed a contract development and manufacturing deal with Cirsium Biosciences, a U.S. biotech firm developing ...
A lack of global capacity to produce cell and gene therapies has been exacerbated by an even more pressing need: to develop and manufacture coronavirus vaccines. So it appears the timing is right for ...
Matica Biotechnology, a CDMO specializing in viral vector manufacturing for cell and gene therapies, reports that it signed a strategic commercial manufacturing agreement with a clinical-stage biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results